Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    Why the Volcker Rule Is Now 233% Longer

    Adding work
    The 2010 Dodd-Frank law was conceived with the best of intentions - curb the bad behavior of the Too Big to Fail banks that caused the 2008 financial crisis. Front and center was the Volcker Rule, which was to stop the banks' risky and dangerous proprietary trading. Three years later the Volcker Rule has yet to see the light of day,
    but how it's changing is what we really need to worry about...
  • Federal Reserve Chairmen